James Lab

Key findings from the Center for Immunity and Immunotherapies highlighted at the American Society of Gene and Cell Therapy’s Annual Meeting from May 16 to 20 in Los Angeles.

We are excited to have Ameena Romani and Parnal Nevekar join the lab. They will be working on engineering and delivery biologics to B cells.

David Rawlings and Rich James start collaboration with Be Biopharma to develop B cell therapies for protein delivery. David and Rich discuss this new therapy in the link above.

We are excited to have Rupa Devi Soligalla and Naomi Sibayan join the lab. They will be both be developing methods to engraft murine antibody secreting cells into normal immune competent hosts.

We are excited to have Andee join us after completing her undergraduate degree at the UW. She will work with the B cell engineering group to improve engineering of loci for expression of proteins by B cells.

We are excited to have Tyler Hill join the lab as a graduate student from the UW MCB program. Tyler plans to focus his studies on engineering human B cells to secrete potentially therapeutic affinity reagents.